{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:49:32Z","timestamp":1794667772751,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.biopha.2023.115096","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T13:58:23Z","timestamp":1688651903000},"page":"115096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Sequentially degradable hydrogel-microsphere loaded with doxorubicin and pioglitazone synergistically inhibits cancer stemness of osteosarcoma"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6703-7948","authenticated-orcid":false,"given":"Jie","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115096_bib1","doi-asserted-by":"crossref","unstructured":"Q. Hu, C. Qian, W. Sun, J. Wang, Z. Chen, H.N. Bomba, H. Xin, Q. Shen, Z.J.A.M. Gu, Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus, 28(43) (2016) 9573\u20139580.","DOI":"10.1002\/adma.201603463"},{"key":"10.1016\/j.biopha.2023.115096_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-018-0880-6","article-title":"HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma","volume":"37","author":"Xiao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.115096_bib3","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.apsb.2021.08.015","article-title":"The FAP alpha-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway","volume":"12","author":"Ye","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"23","key":"10.1016\/j.biopha.2023.115096_bib4","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1002\/cncr.27651","article-title":"Long-term results (> 25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma","volume":"118","author":"Bernthal","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2023.115096_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2017.11.009","article-title":"Drug delivery systems functionalized with bone mineral seeking agents for bone targeted therapeutics","volume":"269","author":"Rotman","year":"2018","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2023.115096_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120404","article-title":"Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges","volume":"265","author":"Gao","year":"2021","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.biopha.2023.115096_bib7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrc1456","article-title":"High interstitial fluid pressure - an obstacle in cancer therapy","volume":"4","author":"Heldin","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2023.115096_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","article-title":"Delivering nanomedicine to solid tumors","volume":"7","author":"Jain","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.biopha.2023.115096_bib9","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1016\/j.biomaterials.2014.04.016","article-title":"Delivery of platinum(IV) drug to subcutaneous tumor and lung metastasis using bradykinin-potentiating peptide-decorated chitosan nanoparticles","volume":"35","author":"Wang","year":"2014","journal-title":"Biomaterials"},{"issue":"13","key":"10.1016\/j.biopha.2023.115096_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201807294","article-title":"Overcoming hypoxia by multistage nanoparticle delivery system to inhibit mitochondrial respiration for photodynamic therapy","volume":"29","author":"Xia","year":"2019","journal-title":"Adv. Funct. Mater."},{"issue":"43","key":"10.1016\/j.biopha.2023.115096_bib11","doi-asserted-by":"crossref","first-page":"24075","DOI":"10.1021\/acsami.5b07116","article-title":"Hybrid collagenase nanocapsules for enhanced nanocarrier penetration in tumoral tissues","volume":"7","author":"Villegas","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.biopha.2023.115096_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1158\/1541-7786.MCR-06-0002","article-title":"Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment","volume":"4","author":"Cairns","year":"2006","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.115096_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202007544","article-title":"Tumor microenvironment\u2010activatable nanoenzymes for mechanical remodeling of extracellular matrix and enhanced tumor chemotherapy","volume":"31","author":"Zhong","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"7","key":"10.1016\/j.biopha.2023.115096_bib14","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1586\/14737140.6.7.1075","article-title":"Chemotherapy resistance in osteosarcoma: current challenges and future directions","volume":"6","author":"Chou","year":"2006","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"W1","key":"10.1016\/j.biopha.2023.115096_bib15","doi-asserted-by":"crossref","first-page":"W160","DOI":"10.1093\/nar\/gkw257","article-title":"deepTools2: a next generation web server for deep-sequencing data analysis","volume":"44","author":"Ramirez","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.biopha.2023.115096_bib16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat. Med."},{"issue":"13","key":"10.1016\/j.biopha.2023.115096_bib17","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.18632\/oncotarget.4037","article-title":"EMT, CTCs and CSCs in tumor relapse and drug-resistance","volume":"6","author":"Mitra","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2023.115096_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116781","article-title":"Cancer stem cell (CSC) resistance drivers","volume":"234","author":"Najafi","year":"2019","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115096_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14737140.2018.1413939","article-title":"Current and future therapeutic approaches for osteosarcoma","volume":"18","author":"Harrison","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"1","key":"10.1016\/j.biopha.2023.115096_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-022-02344-y","article-title":"Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma","volume":"41","author":"Du","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2023.115096_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2016.11.019","article-title":"Cancer stem cells in osteosarcoma","volume":"386","author":"Brown","year":"2017","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.biopha.2023.115096_bib22","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.stemcr.2017.04.025","article-title":"Inhibition of KLF4 by statins reverses adriamycin-induced metastasis and cancer stemness in osteosarcoma cells","volume":"8","author":"Li","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"9","key":"10.1016\/j.biopha.2023.115096_bib23","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1021\/acs.molpharmaceut.8b00457","article-title":"Novel potent ABCB1 modulator, phenethylisoquinoline alkaloid, reverses multidrug resistance in cancer cell","volume":"15","author":"Sugisawa","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2023.115096_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/504918","article-title":"PPAR medicines and human disease: the ABCs of It All","volume":"2012","author":"Apostoli","year":"2012","journal-title":"Ppar Res."},{"issue":"5","key":"10.1016\/j.biopha.2023.115096_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe3445","article-title":"Genome-wide CRISPR-Cas9 screen identified KLF11 as a druggable suppressor for sarcoma cancer stem cells","volume":"7","author":"Wang","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2023.115096_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109356","article-title":"Pioglitazone, an agonist of PPARgamma, reverses doxorubicin-resistance in an osteosarcoma patient-derived orthotopic xenograft model by downregulating P-glycoprotein expression","volume":"118","author":"Higuchi","year":"2019","journal-title":"Biomed. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2023.115096_bib27","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1021\/acsami.6b15245","article-title":"Injectable hydrogel-microsphere construct with sequential degradation for locally synergistic chemotherapy","volume":"9","author":"Zheng","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"27","key":"10.1016\/j.biopha.2023.115096_bib28","doi-asserted-by":"crossref","first-page":"31542","DOI":"10.1021\/acsami.1c08775","article-title":"Curcumin-microsphere\/IR820 hybrid bifunctional hydrogels for in situ osteosarcoma chemo-co-thermal therapy and bone reconstruction","volume":"13","author":"Tan","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2023.115096_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.addr.2012.09.024","article-title":"Environment-sensitive hydrogels for drug delivery","volume":"64","author":"Qiu","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2023.115096_bib30","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1007\/s12274-018-2123-8","article-title":"Entrapping multifunctional dendritic nanoparticles into a hydrogel for local therapeutic delivery and synergetic immunochemotherapy","volume":"11","author":"Jiang","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.biopha.2023.115096_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-015-0383-4","article-title":"Modulation of extracellular matrix in cancer is associated with enhanced tumor cell targeting by bacteriophage vectors","volume":"14","author":"Yata","year":"2015","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2023.115096_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jpha.2014.02.002","article-title":"Pioglitazone: a review of analytical methods","volume":"4","author":"Satheeshkumar","year":"2014","journal-title":"J. Pharm. Anal."},{"issue":"1","key":"10.1016\/j.biopha.2023.115096_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-64480-9","article-title":"Development of a polyvinyl alcohol\/sodium alginate hydrogel-based scaffold incorporating bFGF-encapsulated microspheres for accelerated wound healing","volume":"10","author":"Bahadoran","year":"2020","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115096_bib34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2023.115096_bib35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcis.2018.04.084","article-title":"Hybrid pH-sensitive nanogels surface-functionalized with collagenase for enhanced tumor penetration","volume":"525","author":"Wang","year":"2018","journal-title":"J. Colloid Interface Sci."},{"issue":"6","key":"10.1016\/j.biopha.2023.115096_bib36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.nbt.2011.04.003","article-title":"Production and properties of two collagenases from bacteria and their application for collagen extraction","volume":"28","author":"Suphatharaprateep","year":"2011","journal-title":"N. Biotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115096_bib37","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1096\/fj.10-179036","article-title":"Human primary bone sarcomas contain CD133(+) cancer stem cells displaying high tumorigenicity in vivo","volume":"25","author":"Tirino","year":"2011","journal-title":"Faseb J."},{"issue":"1","key":"10.1016\/j.biopha.2023.115096_bib38","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2023.115096_bib39","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/092986708783503258","article-title":"Strategies to overcome or circumvent P-glycoprotein mediated multidrug resistance","volume":"15","author":"Yuan","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"13\u201314","key":"10.1016\/j.biopha.2023.115096_bib40","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.addr.2013.07.012","article-title":"Role of integrated cancer nanomedicine in overcoming drug resistance","volume":"65","author":"Iyer","year":"2013","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223008879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223008879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:35:29Z","timestamp":1777880129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223008879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":40,"alternative-id":["S0753332223008879"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115096","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequentially degradable hydrogel-microsphere loaded with doxorubicin and pioglitazone synergistically inhibits cancer stemness of osteosarcoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115096"}}